118 related articles for article (PubMed ID: 34222799)
1. The relation between visceral fat markers and cardiometabolic disease risks in psoriasis patients.
Ataseven A; Kutlu R; Uzun L
North Clin Istanb; 2021; 8(3):203-211. PubMed ID: 34222799
[TBL] [Abstract][Full Text] [Related]
2. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
3. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
4. Lipid Accumulation Product Index as Visceral Obesity Indicator in Psoriasis: A Case-control Study.
Ganguly S; Ray L; Kuruvila S; Nanda SK; Ravichandran K
Indian J Dermatol; 2018; 63(2):136-140. PubMed ID: 29692455
[TBL] [Abstract][Full Text] [Related]
5. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
6. Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals.
Barazzoni R; Gortan Cappellari G; Semolic A; Ius M; Zanetti M; Gabrielli A; Vinci P; Guarnieri G; Simon G
Clin Nutr; 2019 Jun; 38(3):1171-1179. PubMed ID: 29779870
[TBL] [Abstract][Full Text] [Related]
7. Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes.
Al-Batsh MMW; Albsoul-Younes A; Kasabri V; Suyagh M; Alalawi S; Yasin N
Horm Mol Biol Clin Investig; 2018 Nov; 36(3):. PubMed ID: 30496135
[TBL] [Abstract][Full Text] [Related]
8. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
9. The visceral adiposity index, lipid accumulation product, and plasma atherogenic index are associated with subclinical atherosclerosis in patients with newly diagnosed acromegaly.
Özbek M; Çalapkulu M; Hepşen S; Sencar ME; Bostan H; Öztürk Ünsal İ; Çakal E
Turk J Med Sci; 2021 Oct; 51(5):2600-2606. PubMed ID: 36441155
[TBL] [Abstract][Full Text] [Related]
10. SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.
Numan Ahmad M; Halim Haddad F
Nutr Hosp; 2015 Dec; 32(6):2701-9. PubMed ID: 26667723
[TBL] [Abstract][Full Text] [Related]
11. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity index and lipid accumulation product index: The promising role in assessing cardiometabolic risk in non-obese patients of PCOS.
Bir A; Ghosh A; Chowdhury S
J Educ Health Promot; 2023; 12():148. PubMed ID: 37404927
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte to High-density Lipoprotein Cholesterol Ratio is Positively Associated with Pre-diabetes, Metabolic Syndrome, and Non-traditional Cardiometabolic Risk Markers: A Cross-sectional Study at Secondary Health Care.
Cândido FG; da Silva A; Zanirate GA; Oliveira NMCE; Hermsdorff HHM
Inflammation; 2024 Jun; ():. PubMed ID: 38844648
[TBL] [Abstract][Full Text] [Related]
14. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
15. Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.
Dai D; Chang Y; Chen Y; Chen S; Yu S; Guo X; Sun Y
Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27983609
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between visceral obesity and atherosclerosis in hemodialysis patients].
He PH; Min YL; Zhou CM; Tong XY; Lin X; Li Q; Zha Y
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3411-3414. PubMed ID: 30440135
[No Abstract] [Full Text] [Related]
17. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
[TBL] [Abstract][Full Text] [Related]
18. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
19. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
Ramezani Tehrani F; Minooee S; Azizi F
Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
[TBL] [Abstract][Full Text] [Related]
20. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
